Tart cherry juice may improve sleep quantity and quality in older adults with self-reported insomnia
This protocol describes a randomized, double-blind, placebo-controlled, cross-over pilot study testing 16 oz. of tart cherry juice daily for 4 weeks in 20 older adults with self-reported insomnia. The study aims to evaluate feasibility and collect preliminary data on sleep quantity/quality and biomarkers related to melatonin, cortisol, serotonin, and inflammation.
Evidence Score
Study Evidence
Study 1. CherryZZZ: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study Testing Tart Cherry Juice in Older Adults with Self-Reported Insomnia.
observationalVanderMark E, Baniassadi A, Wolfe A, Cladis DP, Dufour AB, Millar CL ยท Nutrients (2026)
Result:
Mechanism Graph
Limitations
- โ This is a protocol paper; no results are reported yet
- โ Small sample size (n=20) limits generalizability
- โ Self-reported insomnia may not align with objective sleep measures
Frequently Asked Questions
What is the proposed dose of tart cherry juice for sleep improvement?โผ
The protocol uses 16 oz. per day, split into 8 oz. in the morning and 8 oz. at night, for 4 weeks.
Who is the target population for this study?โผ
Older adults with self-reported insomnia.
What outcomes are being measured in this pilot study?โผ
Feasibility (recruitment, retention, compliance, safety), sleep quantity/quality via diaries and wearable devices, and biomarkers such as melatonin, cortisol, serotonin, and inflammation.
Is this study a randomized controlled trial?โผ
Yes, it is a randomized, double-blind, placebo-controlled, cross-over pilot study.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.VanderMark E, Baniassadi A, Wolfe A, Cladis DP, Dufour AB, Millar CL. "CherryZZZ: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study Testing Tart Cherry Juice in Older Adults with Self-Reported Insomnia.." Nutrients, 2026. PMID: 41901097 DOI: 10.3390/nu18060922